XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities:    
Net loss $ (514,329) $ (1,044,736)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 62,834 97,546
Warranty provision 111,369 26,303
Inventory obsolescence (181,486) 11,067
Share-based compensation 642,151 308,257
Deferred income taxes (317,243) (857,706)
Changes in operating assets and liabilities:    
Accounts receivable 168,183 (361,037)
Inventories (174,720) (287,325)
Prepaid expenses and other (101,304) (82,637)
Other assets 133,188 93,742
Accounts payable 707,549 738,256
Warranty settlements (19,212) (24,099)
Accrued and other liabilities 540,587 1,172,443
Net cash provided by (used in) operating activities 1,057,567 (209,926)
Investing Activities:    
Sales (purchases) of marketable securities 101,293 (612,219)
Capital expenditures (57,473) (126,594)
Patent costs paid (4,286) (5,658)
Net cash provided by (used in) investing activities 39,534 (744,471)
Financing Activities:    
Repurchase of common stock (1,748,456)
Common stock cash dividends paid (636,661)
Net cash used in financing activities (2,385,117)
Net increase (decrease) in cash 1,097,101 (3,339,514)
Cash and cash equivalents, beginning of period 13,466,711 18,316,103
Cash and cash equivalents, end of period $ 14,563,812 $ 14,976,589